Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine and Paroxetine Strategy in MDD Non-Responders
NCT01458626Phase 4Completed
- Sponsor
- Capital Medical University
- Start
- Nov 2012
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirtazapine in major depressive disorder (MDD), sponsored by Capital Medical University. Started Nov 2012; status: completed.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01458626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01458626.